Aryl and heteroaryl compounds, compositions, methods of use
申请人:Mjalli M.M. Adnan
公开号:US20050171148A1
公开(公告)日:2005-08-04
This invention provides aryl and heteroaryl compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention may be useful as antagonists, or partial antagonist of factor IX and/or factor XI and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds may be useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX and/or XI.
Aryl and Heteroaryl Compounds, Compositions, Methods of Use
申请人:Mjalli Adnan M.M.
公开号:US20090124654A1
公开(公告)日:2009-05-14
This invention provides aryl and heteroaryl compounds of formula (X). The compounds of the invention may be useful as antagonists, or partial antagonist of factor IX and/or factor XI and thus, may be used to inhibit the intrinsic pathway of blood coagulation. Formula (X) wherein R
102
is selected from the group consisting of —C(O)OH, —C(O)OCH
3
, —C(O)O-t-butyl, —C(O)NH—OCH
2
-phenyl, C(O)NHOH, and —C(O)NHSO
2
CH
3
; and wherein R
101
, R
103
, R
104
and Y are as defined herein.
Aryl and heteroaryl compounds, compositions, and methods of use
申请人:Mjalli M.M. Adnan
公开号:US20070254916A1
公开(公告)日:2007-11-01
This invention provides aryl and heteroaryl compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention may be useful as antagonists, or partial antagonist of factor IX and/or factor XI and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds may be useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX and/or XI.